Dobutamine Hydrochloride Injection — FDA Drug Shortage

Current — Hospira, Inc., A Pfizer Company

The FDA lists a drug shortage record for Dobutamine Hydrochloride Injection (injection) from Hospira, Inc., A Pfizer Company with status Current. The shortage was first posted on Nov 6, 2017.

Shortage details

Status
Current
Company
Hospira, Inc., A Pfizer Company
Package NDC
0409-1100-10
Dosage Form
Injection
Presentation
Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 1,000 mg/250mL (4 mg/mL) (NDC 0409-1100-10)
Initial Posting
Nov 6, 2017

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.